← Eichor
Study identifier: NCT05868408 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants

Condition: Infant Nutritional Physiological Phenomena · Infant Formula · Infant Health  ·  Sponsor: Société des Produits Nestlé (SPN)

PhaseNA
Planned participants234
Who can joinAll sexes, 0 Days to 28 Days
Healthy volunteersYes

About this study

This study will assess the effect of partially hydrolyzed, whey-based infant formulas on growth and gastrointestinal tolerance in healthy term infants.

This description comes directly from the study's public registry record.

Talk to the study team

Qiaoji Li  ·  +861087419794  ·  qiaoji.li@rd.nestle.com

Always discuss trial participation with your own doctor first.

Locations (5)

Biomedical Research InstituteCavite City, PhilippinesRecruiting
Biomedical Research InstituteLas Piñas, PhilippinesRecruiting
National Guard HospitalJeddah, Saudi ArabiaActive Not Recruiting
King Faisal Specialist Hospital and Research CenterRiyadh, Saudi ArabiaCompleted
National Guard HospitalRiyadh, Saudi ArabiaCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05868408